Cita APA

Brand, T. M., Dunn, E. F., Iida, M., Myers, R. A., Kostopoulos, K. T., Li, C., . . . Wheeler, D. L. (2011). Erlotinib is a viable treatment for tumors with acquired resistance to cetuximab. Landes Bioscience.

Chicago Style Citation

Brand, Toni M., Emily F. Dunn, Mari Iida, Rebecca A. Myers, Kellie T. Kostopoulos, Chunrong Li, Chimera R. Peet, i Deric L. Wheeler. Erlotinib Is a Viable Treatment for Tumors With Acquired Resistance to Cetuximab. Landes Bioscience, 2011.

Cita MLA

Brand, Toni M., et al. Erlotinib Is a Viable Treatment for Tumors With Acquired Resistance to Cetuximab. Landes Bioscience, 2011.